| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $8.3M | +18.0% |
| Cost of Revenue | $4.9M | +15.7% |
| Gross Profit | $3.3M | +21.7% |
| R&D Expense | $429K | -56.0% |
| SG&A Expense | $3.4M | -15.2% |
| Operating Income | -$3.9M | +41.5% |
| Pre-tax Income | -$4.0M | +40.5% |
| Income Tax | -$333K | +0.0% |
| Net Income | -$4.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.9M | +123.1% |
| Accounts Receivable | $278K | -54.8% |
| Inventory | $2.8M | -2.9% |
| Current Assets | $9.1M | +36.9% |
| Total Assets | $10.1M | +11.9% |
| Current Liabilities | $3.0M | -22.7% |
| Long-term Debt | $146K | -41.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.1M | +49.4% |
| Capital Expenditures | $7K | +0.0% |
| Investing Cash Flow | $53K | +857.1% |
| Financing Cash Flow | $5.6M | -8.8% |
| Free Cash Flow | -$3.1M | +49.3% |
| +37.4% |
| EPS (Basic) | -$20.40 | -716.0% |
| EPS (Diluted) | -$4.39 | -75.6% |
| Total Liabilities |
| $3.1M |
| -26.0% |
| Stockholders' Equity | $6.9M | +45.9% |